AAMC Discusses Monoclonal Antibody Therapeutics for SARS-CoV-2 Infection.

Donnenberg, Vera S

Donnenberg, Vera S.

Donnenberg VS; Department of Cardiothoracic Surgery, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.

J Clin Pharmacol ; 61(3): 280-281, 2021 03.

Article in English | MEDLINE | ID: covidwho-1064376

Subject(s)

Antibodies, Monoclonal/therapeutic use; COVID-19 Drug Treatment; Immunologic Factors/therapeutic use; National Institutes of Health (U.S.); Schools, Medical; Antibodies, Monoclonal/pharmacology; Antibodies, Viral/drug effects; Antibodies, Viral/physiology; COVID-19/epidemiology; Humans; Leadership; United States/epidemiology

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Schools, Medical / COVID-19 Drug Treatment / Immunologic Factors / Antibodies, Monoclonal / National Institutes of Health (U.S.) Type of study: Observational study Limits: Humans Country/Region as subject: North America Language: English Journal: J Clin Pharmacol Year: 2021 Document Type: Article Affiliation country: Jcph.1820

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google